Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

Completed

Conditions studied: Ocular Melanoma, Choroidal Melanoma, Uveal Melanoma

In brief

Patients diagnosed with ocular melanoma consent to participate in the study. Combined PET/CT scans of the whole body are performed at baseline, three months later, and six months after that for a total of three combined scans in the first year. Subsequently, these combined scans will be performed at 6-monthly intervals for a total of two combined scans per year.

Key facts

Study ID

NCT00351728

Run by

Jonsson Comprehensive Cancer Center

People needed

174

Starts

2006-06-01

Expected to finish

2012-08-01

Last updated by the study team

2016-07-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a diagnosis of ocular melanoma (a pigmented malignant tumor) involving the choroid and/or ciliary body (the blood vessel layer in the back of the eye and/or the part of the eye behind the iris).
• Patients 18 years of age or older.
• Patients able to give informed consent.

You may not qualify if…

• Patients who refuse to participate in the study.
• Patients who are unable to cooperate with or cannot undergo PET/CT scanning.
• Patients who will be moving out of the area of UCLA during the ten years of this study.

Where it is running

• Jules Stein Eye Institute — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.